Views & Analysis Let’s talk about drugs Paul Tunnah asks if we need to rethink pharma's strict marketing regulations and have a discussion on how best to communicate with patients
Views & Analysis The biggest challenge facing pharma? Its own organisation an... Pharma marketers have to focus on benefitting patients, not return on investment.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
